A Prospective Open‐Label Observational Study of a Buffered Soluble 70 mg Alendronate Effervescent Tablet on Upper Gastrointestinal Safety and Medication Errors: The GastroPASS Study-Reference-Cited by-同舟云学术

A Prospective Open‐Label Observational Study of a Buffered Soluble 70 mg Alendronate Effervescent Tablet on Upper Gastrointestinal Safety and Medication Errors: The GastroPASS Study

Published:2021-05-17 Issue:7 Volume:5 Page:
ISSN:2473-4039
Container-title:JBMR Plus
language:en
Short-container-title:JBMR Plus

Author:

Minisola Salvatore¹^ORCID,Vargas Antonio P²,Letizia Mauro Giulia³,Bonet Madurga Fernando⁴,Adami Giovanni⁵^ORCID,Black Dennis M⁶^ORCID,Qizilbash Nawab⁷⁸,Blanch‐Rubió Josep⁹^ORCID

Affiliation:

1. Department of Clinical, Internal, Anaesthesiology, and Cardiovascular Sciences Sapienza University of Rome Rome Italy

2. SEPAR, S.L. (Private Clinic), Calle Linaje Malaga Spain

3. Department of Surgical, Oncologic, and Stomatologic Disciplines University of Palermo Palermo Italy

4. MDS 360 (Private Clinic), Chamartín Madrid Spain

5. Division of Rheumatology, Department of Medicine University and Azienda Ospedaliera Universitaria Integrata of Verona Verona Italy

6. University of California San Francisco CA USA

7. Epidemiology and Risk Management, Oxon Epidemiology Madrid Spain

8. Faculty of Epidemiology and Population Health London School of Hygiene and Tropical Medicine London UK

9. Rheumatology Service Hospital del Mar, Passeig Marítim and IMIM (Hospital del Mar Medical Research Institute), Parc de Recerca Biomèdica de Barcelona Barcelona Spain

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jbm4.10510

Reference35 articles.

1. Postmenopausal osteoporosis

2. Osteoporotic fractures: mortality and quality of life;Caliri A;Panminerva Med.,2007

3. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures

4. National Institute for Health and Care Excellence. Overview: bisphosphonates for treating osteoporosis [Internet]. Available at:https://www.nice.org.uk/guidance/ta464. Accessed Feb 5 2020.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sequential management of postmenopausal health and osteoporosis: An update;Maturitas;2023-11

2. Bisphosphonates and osteonecrosis of the jaws: Clinical and forensic aspects;Archives of Oral Biology;2023-11

3. The Effect of Effervescent and Buffered Alendronate Compared to Conventional Alendronate on Markers of Bone Turnover: A Randomized Non-inferiority Trial;Calcified Tissue International;2023-10-06

4. Quercetin alleviates osteoporosis in rat mandibles induced by ovariectomy through modulation of autophagy and inhibition of NLRP3 pathway;2023-04-06

5. Novel formulations of oral bisphosphonates in the treatment of osteoporosis;Aging Clinical and Experimental Research;2022-11-04